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Abstract
ClC chloride channels and transporters are found in virtually every living cell and they
are key players in a variety of physiological processes. The nine family members expressed
in human are involved in diverse physiological functions ranging from the stabilization of
membrane potentials, transepithelial transport of salt and water to the acidiﬁcation of
intracellular vesicles. Their essential roles in the organism are emphasized by hereditary
diseases arising from ClC malfunction like myotonia, Dent's disease, Bartter's syndrome
or osteopetrosis.
Structures of two bacterial homologs serve as a structural framework for the transmem-
brane region of the protein family. However, these crystal structures do not account for
large cytoplasmic domains that are inherent to all human ClCs. These intracellular parts
of the protein have been shown to be crucial for protein function and to be involved in
the functional regulation of chloride transport. The precise role of these cytoplasmic
domains in the context of the ClC family is unclear, although they have been associated
with processes like the regulation of channel gating or ligand binding. Despite these
functional implications only limited biochemical and no structural information on the
organization of these domains was available. Therefore it was the aim of my PhD project
to structurally and functionally characterize the cytoplasmic domains of ClC channels
and transporters.
These domains were studied in the context of two members of the ClC family, the voltage-
gated chloride channel ClC-0 from Torpedo marmorata and the human secondary active
transporter ClC-5.
The structure of the isolated domains from ClC-0 provided the ﬁrst atomic model of
the ClC intracellular domains, thus revealing the structural organization of the pro-
tein including the organization of the two cystathionine-β-synthase (CBS) subdomains
present in all eukaryotic ClCs. In addition it was established by analytical ultracen-
trifugation that the isolated cytoplasmic domains assemble as protein dimers in solution,
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thereby extending the dimeric arrangement observed for the transmembrane domains.
The structural studies on the domains from ClC-0 led to the discovery of extended na-
tively disordered sequence stretches in the intracellular domains of a branch in the ClC
family. In a study in collaboration with Prof. K. Pervushin from the ETH Zürich the
dynamic properties of these functionally relevant segments have been characterized with
nuclear magnetic resonance techniques.
The work conducted on the human transporter ClC-5 led to the structures of the isolated
domains in complex with bound ATP and ADP. This is the ﬁrst structure of any CBS
domain protein with its nucleotide ligand revealing a novel ATP binding site and the
molecular determinants of nucleotide recognition. The aﬃnities of the cytoplasmic do-
mains for adenosine nucleotides were determined and, under certain conditions, a modu-
lation of ClC-5 activity could be correlated with nucleotide binding in electrophysiological
measurements. Additionally, the crystal structure of the cytoplasmic domains revealed
a novel dimeric arrangement.
In summary, the studies presented in this work provide the ﬁrst high resolution structures
for these important regulatory modules in ClC proteins. Structural and functional char-
acterization revealed the oligomeric assembly of these domains, as well as the molecular
interaction with adenosine ligands and aspects of their regulatory eﬀects, an emerging
facet of ClC modulation.
VIII
Zusammenfassung
Die Familie der ClC Chlorid Kanäle und Transporter sind an einer Vielzahl von wichtigen
zellulären Prozeßen beteiligt und in nahezu allen lebenden Zellen zu ﬁnden. Die neun
im Menschen vorkommenden Homologe tragen maßgeblich zu verschiedensten physio-
logischen Mechanismen bei, beginnend bei der Stabilisation von Membranpotentialen,
über den Transport von Salzen und Wasser durch Zellepithele bis zur Ansäuerung von
intrazellulären Kompartimenten. Ihre Wichtigkeit für den Organismus wird deutlich
durch verschiedene erblich bedingte Krankheiten, die auf Fehlfunktionen in ClC Pro-
teinen beruhen, wie Myotonie, die Syndrome Dent und Bartter sowie Osteopetrose.
Die Kristallstrukturen von zwei prokaryotischen ClC Homologen dienen als Modelle für
den strukturellen Aufbau der membranständigen katalytischen Domäne der Protein-
familie. In diesen Strukturen fehlen jedoch große zytoplasmatische Domänen, die Teil
aller humaner ClC Proteine sind. Diese intrazellulären Domänen sind essentiell für die
Funktion der Proteine und zudem an der Regulation des Chloridtransports beteiligt. Die
genaue Funktionsweise dieser Proteindomänen in den ClC Kanälen und Transportern
ist noch ungeklärt, obwohl sie mit der Regulation der Kanalaktivität oder auch mit
Ligandenbindung in Verbindung gebracht wurden. Trotz dieser ersten Hinweise auf ihre
funktionelle Rolle gab es nur wenige biochemische, und so gut wie keine strukturellen In-
formationen über ihre Organisation. Aus diesem Grunde war es Ziel meiner Doktorarbeit
die zytplasmatischen Domänen der ClC Familie strukturell und funktionell genauer zu
untersuchen.
Diese Untersuchungen wurden am Beispiel von zwei ClC Proteinen durchgeführt, dem
spannungsabhängigen Chloridkanal ClC-0 aus Torpedo marmorata sowie dem humanen
sekundär aktiven Transporter ClC-5.
Die Struktur der isolierten Domänen aus ClC-0 stellt das erste Modell mit atomarer
Auflösung der intrazellulären Domänen der ClC Familie dar. Die Kristallstruktur gibt
Aufschluß über den Aufbau der Domänen und zeigt die Organisation von zwei Sub-
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domänen, die nach der Cystathionin-Synthetase (CBS) benannt sind. Diese Subdomänen
kommen in allen eukaryotischen ClC Proteinen vor. Zudem konnte in dieser Studie mit
Hilfe von analytischer Ultrazentrifugation gezeigt werden, daß die isolierten Domänen,
ähnlich wie die katalytischen Membrandomänen, in Lösung dimerisieren. Des weiteren
wurden anhand dieser strukturellen Untersuchungen innerhalb der zytoplasmatischen
Proteinregionen von ClC-0 Bereiche entdeckt, die als intrinsisch ungeordnete Sequen-
zen vorliegen. Diese Sequenzbereiche sind nur in einer Untergruppe der ClC Proteine
zu ﬁnden, scheinen aber wichtige Motive für deren Funktionsregulation zu beinhalten.
In einer Zusammenarbeit mit Prof. K. Pervushin von der ETH Zürich wurden die
dynamischen Eigenschaften dieser Proteinsequenzen mit Kernspinresonanzspektroskopie
genauer charakterisiert.
Die am humanen Transportprotein ClC-5 vorgenommenen Untersuchungen führten zu
den Kristallstrukturen der isolierten zytplasmatischen Domänen im Komplex mit ATP
sowie ADP. Diese stellen die ersten Strukturen von Proteinen dar, die die molekulare
Interaktion von CBS Subdomänen mit ihren Nukleotidliganden zeigen. Die Bindungs-
aﬃnitäten der Domänen für Adenosinnukleotide wurden durch Gleichgewichtsdialysen
bestimmt. Zudem konnte in elektrophysiologischen Messungen unter bestimmten Be-
dingungen eine veränderte Aktivität des ClC-5 mit dem Bindungsverhalten des Liganden
korreliert werden. Darüber hinaus ist in der Kristallstruktur erstmals die Dimerisierung
zweier intrazellulärer ClC Domänen zu sehen.
Alles in allem zeigen die in dieser Arbeit vorgelegten Studien die ersten hoch auf-
lösenden Kristallstrukturen dieser wichtigen Proteinmodule mit regulativer Funktion
in der ClC Protein Familie. Die strukturelle und funktionelle Charakterisierung dieser
Domänen führte zur Aufklärung verschiedener wesentlicher Sachverhalte. So wurde die
Oligomerisierung dieser Proteinteile , die Interaktion mit Adenosinliganden auf moleku-
lare Ebene sowie Aspekte ihrer regulatorischen Wirkung beschrieben.
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Outline
The 'Introduction' section gives a concise overview of the ﬁeld of ClC channels and trans-
porters touching on the general features like physiological functions, molecular architec-
ture and ion conduction and selectivity. A more detailed perspective on the importance
of the cytoplasmic domains in ClCs is given at the current status of research including
the work presented in the later sections. The 'Results' section is structured into two
chapters, one dealing with the work on the cytoplasmic domains from the voltage-gated
chloride channel from ClC-0, the other describing the work on the cytoplasmic domains
from the secondary active transporter ClC-5. Each chapter includes a short introduc-
tion sketching the status of the research prior to the studies and an aim formulating
the key questions for each study. The core of the chapters are the experimental results
that have led to three publications in peer reviewed journals. The articles are included
in the thesis as they have been published, in the case of the work on the cytoplasmic
domains of ClC-0 in Structure1 and the Journal of Molecular Biology2 and for the work
on the domains from ClC-5 in Nature Structural and Molecular Biology.3 In addition
to these documents some supplementary information is appended giving more detailed
methodological information and further results.
The section 'Concluding Remarks and Outlook' is intended to sum up the major ﬁndings
of these studies, placing them in the context of the current questions in the ClC ﬁeld.
The unresolved issues concerning the detailed mechanisms and functions of ClCs lead to
an outlook on the possible future strategies.
The 'Appendix' includes a chapter on the cloning, expression, and biochemical charac-
terization of an archaebacterial ClC homolog, an intergral membrane protein that was
studied towards the aim of resolving the structural organization of the cytoplasmic do-
mains in the context of the catalytic pore domain.
XI
Outline
XII
Chapter 1
Introduction
1.1 Principles of Ion Transport
Every living cell is surrounded by a lipid membrane separating the cytoplasm from the
environment. The hydrophobic core of the membrane serves as a barrier that is im-
permeable to solutes, thereby allowing the cell to keep its interior separated from the
extracellular surrounding. In order to exchange solutes with the environment life had to
develop speciﬁc proteins that catalyze the movement of solutes across membranes. Using
these proteins the cell is able to generate deﬁned conditions needed for the diﬀerent cel-
lular processes in the cytoplasm or intracellular compartments.
In addition to the translocation of metabolites, the selective transport of ions across
biological membranes is an essential feature of all living cells. Much of the metabolic
energy of the cell is spent by molecular pumps to establish ion gradients, which in turn
drive many of the fundamental tasks performed in the cell. The movement of potassium,
sodium, calcium and chloride underlies important processes like solute and electrolyte
uptake, chemical and electric signaling or cell volume homeostasis. Organisms have
evolved a variety of diﬀerent proteins that catalyze the translocation of ions across the
hydrophobic core of cellular membranes.
Channels and Transporters Generally, two diﬀerent classes of ion transport pro-
teins are distinguished based on their thermodynamically diﬀerent modes of action. Ion
channels are permitting the passive diﬀusion of ions along their electrochemical gra-
dient, while transporters use energy either from ATP hydrolysis or the dissipation of
an electrochemical potential to move ions against their electrochemical gradient. In a
1
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Figure 1: Channels and Transporters
A schematic comparison of the mechanism
of ion channels and ion transporters. Ion
channels (A) simply allow passive diﬀusion
of ions. Upon channel opening state I to
II selected ions can pass through the pore
along their electrochemical gradient, as indi-
cated by the green arrow. Ion transporters
(B) undergo a more complex cycle of dif-
ferent states. Substrate has to bind on one
side of the membrane and the protein under-
goes a structural re-arrangement releasing
the substrate on the other side. This process
allows accumulation of substrate against its
electrochemical gradient requiring the con-
certed input of energy either from ATP hy-
drolysis or the dissipation of another ion
gradient.
classical perspective the two classes of ion conducting proteins operate via distinct mech-
anisms. Ion channels are thought of as ion selective pores in the membrane that allow the
passive diﬀusion of ions across the membrane. They are regulated by the opening and
closing of gates that are able to plug the pore rendering the channel closed. This gating
mechanism is in the simplest view a two-state process switching the channel on and oﬀ
like depicted in Figure 1A. In ion transporters on the other hand one of the main features
is the coupling of ion translocation to a secondary driving force like the hydrolysis of ATP
or the transport of another ion species. This allows to link an energy consuming process,
like an ion movement against an electrochemical gradient, to an energetically favorable
event, like the downhill movement of an ion along its electrochemical gradient. The pro-
cess of driving one energy dependent reaction by a second exergonic event requires tight
coupling of these reactions to avoid the favorable reaction to independently occur and
waste energy. In accordance to this the need for coupling imposes the necessity to have a
more elaborate translocation cycle, where the protein passes through several states. The
transport cycle is usually accompanied by large conformational changes in the protein
granting alternate access of the substrate binding pocket to either side of the membrane
(Figure 1B).
Like enzymes both channels and transporters can be characterized by several key prop-
erties: 1. Ion selectivity, a measure for the substrate speciﬁcity; 2. Ion conductance,
an equivalent to the catalytic turnover of the protein; 3. Activation of ion transport,
2
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which is called gating in channels, describes the regulation of the enzymatic activity. To
meet the requirements of eﬃcient ion movement, high ﬁdelity and tight control of the
activity, transport proteins are frequently organized in a modular fashion consisting of
catalytic and regulatory domains. The catalytic domain is embedded in the membrane
and provides the structural scaﬀold to form an ion pathway across the hydrophobic in-
terior of the membrane. It makes speciﬁc interactions with the respective substrate and
is therefore essential to establish selectivity by binding the substrate and conduction by
releasing the substrate to the other side of the membrane. Regulatory domains often
accompany the catalytic domains and modulate their activity in response to diﬀerent
stimuli like membrane voltage,4 ligand binding5,6 or mechanic pressure.7 These domains
tune the activity of the transport protein by a mechanism called gating.
Chloride Transport Of the diﬀerent ions that function as substrates for channels
and transporters the most abundant in biological systems are potassium, sodium, cal-
cium and chloride. Each ion has its own set of proteins that evolved speciﬁcally for its
transport with high eﬃciency. Chloride is by far the most prevalent anion in nature. Sev-
eral distinct families of chloride transporting enzymes are well established by functional
characterization: ClC channels and transporters, ligand-gated GABA and glycine recep-
tors, Cystic Fibrosis Conductance Transmembrane Regulator (CFTR), Chloride Cation
Co-transporters or the Cl−/HCO−3 exchangers. These proteins reside both in the plasma
membrane and intracellular organelles and they function in a variety of essential pro-
cesses like regulation of electrical excitability, transepithelial transport, ion homeostasis
and cell volume regulation.8,9 Their physiological importance is illustrated by several
hereditary diseases like Bartter's syndrome, cystic ﬁbrosis, Dent's disease or myotonia.10
The ClC family of chloride channels and transporters has recently been recognized as
unique among ion transport proteins, since the same structural scaﬀold is used to sup-
port passive chloride conduction and the secondary active transport of chloride against
protons.11
1.2 ClC Chloride Channels and Transporters
1.2.1 History
ClC chloride channels and transporters are ubiquitous in biological systems; they are
found in all phylae from bacteria to humans. These proteins are expressed in almost
3
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every living cell and serve a variety of functions. ClC proteins are involved in the stabi-
lization of membrane potentials, transepithelial transport or the acidiﬁcation of intracel-
lular vesicles.12 The initial breakthrough in the ClC research ﬁeld was the description of
ClC chloride conduction back in 1980 when protein from the electric ray Torpedo cali-
fornica could be functionally reconstituted and characterized.13 The name ClC resulted
from this period from the term Cl− Channel. It took until 1990 when expression cloning
revealed the sequence of ClC-0, the voltage-gated chloride channel from Torpedo mar-
morata.14 This quickly led to the identiﬁcation of nine homologs in human allowing for
characterization by heterologous expression techniques.1520 Another signiﬁcant advance
in the understanding of ClC function came from the high resolution structures of two
bacterial homologs.21 The crystal structures allowed for the ﬁrst time to visualize the
complex topology of the membrane embedded catalytic domain and the architecture of
the ion translocation pore of this protein family.22
1.2.2 The ClC Family
The nine homologs found in humans can be grouped based on sequence homology into
three subfamilies (α, β, γ).23 ClC-0, the channel from the electroplax organ of the elec-
tric ray, is included in this enumeration due to its high sequence homology and thorough
characterization that makes it a paradigm for ClC channel function. The α-subfamily
is comprised of the voltage-gated chloride channels ClC-1, ClC-2, ClC-Ka and ClC-Kb
that are expressed in the plasma membrane. The members of the two other branches are
predominantly located in intracellular vesicles making the electrophysiological charac-
terization diﬃcult. ClC-4 and ClC-5 from the β-subfamily can under certain conditions
be traﬃcked to the plasma membrane and could therefore be studied in heterologous
expression.19,24 These proteins have been recently shown to function as secondary active
chloride proton antiporters.25,26 The homologs ClC-6 and ClC-7 of the γ-subfamily on
the other hand are exclusively residing in intracellular compartments and have so far
eluded functional characterization. It is to this point unclear if all the intracellular ClC
proteins function as transporters although some hints exist on the level of the primary
sequence.27 Consistently it has been shown that the homologous protein in E.coli that
serves as a structural model for the entire protein family is acting as an antiporter.28
Some family members require additional β-subunits to exert their proper function as in
the case of ClC-Ka, ClC-Kb or ClC-7.29,30 It is unclear however, whether this is due to a
modulation of the conductance properties or sorting and traﬃcking eﬀects.31 Although
4
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Figure 2: Dendrogram of Mammalian ClC Proteins
Based on sequence homology the nine ClC family members from human can be devided into
three subfamilies. The well characterized ClC from Torpedo can be grouped to the α-subfamily.
The columns state important features of each family member, like tissue distribution, presumed
function and associated human diseases.
not all of the family members have been studied on the molecular level, a lot of insight
into their physiological roles could be derived from mouse knock-out models that allowed
in many cases subsequent linking to human hereditary diseases.32
1.2.3 Physiological Function, Expression and Disease
The nine ClC homologs found in humans are involved in a variety of diﬀerent cellu-
lar processes, a property that is reﬂected by diﬀering expression patterns and cellular
localization.33 For most of the family members some physiological function could be
pinpointed due to the combined use of mouse models and by linking the observed pheno-
types to the inactivation of ClCs in human disease. In the following a concise overview
will be given of the diﬀerent ClC proteins found in human and their proposed function,
expression patterns and resulting pathologies.
α-Subfamily ClC-1 is a voltage-gated chloride channel, expressed almost exclusively
in skeletal muscle and the closest homolog to ClC-0 from the Torpedo electric organ.
5
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The resting conductance of skeletal muscle is dominated by chloride currents mediated
by ClC-1 instead of potassium currents.34 Thereby ClC-1 is responsible for the stabi-
lization of the resting potential as well as for the repolarization of the membrane after
action potentials.15 Mutation in ClC-1, which cause a reduction of the conductance or
an altered voltage dependence, lead to myotonia congenita in human patients.35 This
symptom is marked by an impairment of muscle relaxation after voluntary contraction
impressively demonstrated by the example of the animal model of the myotonic or faint-
ing goat strain.36
ClC-2 is a chloride channel with an ubiquitous expression pattern.16 The channel is regu-
lated by a variety of diﬀerent stimuli like hyperpolarization, cell swelling or extracellular
pH, thus making it a candidate for various functions. The speculative involvement in
epilepsy37 could not be conﬁrmed by the analysis of ClC-2 knock-out mice, which in
contrast display testicular and retinal degeneration.38 In summary the precise role of
this channel remains uncertain as well as its involvement in human disease.
The two paralogs ClC-Ka and ClC-Kb are highly homologous (94 % sequence identity)
and are expressed speciﬁcally in the kidney and the inner ear with only slightly diﬀering
expression patterns.17 Both channels are involved in transepithelial salt transport and
impairment in any of the two leads to the renal salt wasting disorder Bartter's disease.39
These were the ﬁrst ClC proteins that were recognized to require a β-subunit, in this
case Barttin, to exert their physiological function.29
β-Subfamily ClC-3 is the ﬁrst ClC in the closely related group of ClC-3,-4 and -5
that reside mainly in intracellular compartments.40 This protein is widely expressed
and is diﬃcult to study due to its subcellular localization in endosomal and lysosomal
compartments and synaptic vesicles. Despite a severe phenotype of ClC-3 knock-out
mice showing degeneration of the hippocampus and the retina no corresponding disease
in humans could be identiﬁed.40
The secondary active transporter ClC-4 is broadly expressed and is predominantly found
in intracellular membranes.41 Similar to the afterwards discussed ClC-5 this protein can
reach the plasma membrane to a certain degree when expressed heterologously.42 The
physiological relevance of the currents measured at the plasma membrane is puzzling
since both proteins exhibit a strong rectiﬁcation, conducting only at membrane potentials
larger than +20 mV, a situation unlikely to be reached under physiological conditions
in the plasma membrane or intracellular membranes. Hence, the physiological role of
ClC-4 remains unclear, although it has been proposed to be involved in hepatic copper
6
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metabolism.43
The transporter ClC-5 is expressed in most tissues while being most abundant in kidney
and intestine,19 where it was found to be involved in endocytosis.44 On the subcellular
level, it is found predominantly in endosomes, where it co-localizes with the vesicular
H+-ATPase.45 In these vesicles ClC-5 is presumed to dissipate the electric potential
created by the ATPase during acidiﬁcation of the endosomes.45 The detailed mechanism
however is obscured by the recent ﬁndings that show chloride to proton exchange activity
of the protein.25,26 Malfunction of ClC-5 leads to Dent's disease, an x-chromosome-linked
disorder associated with proteinuria and kidney stones.46
γ-Subfamily The intracellular protein ClC-6 and ClC-7 constitute another branch in
the ClC family with about 45 % sequence identity. ClC-6 is almost exclusively expressed
in the central and peripheral nervous system, where it is found in late endosomes.20 The
analysis of mice with disrupted ClC-6 revealed a reduced pain sensitivity and hints at
a lysosomal storage disease.47 Although the later phenotype resembles neuronal ceroid
lipofuscinosis, a disease found in humans, a correlation of ClC-6 defects in patients re-
mains to be shown.
ClC-7 is another intracellularly located protein that is ubiquitously expressed and lo-
calizes to late endosomes and lysosomes.20 It is by far the most predominant ClC
protein present in lysosomes, additionally it is also found in the rued border of os-
teoclasts.48 These specialized membrane domains are facing the resorbtion lacuna of
this bone-degrading cell type and resemble an extracellular lysosome in its composi-
tion. ClC-7 co-localizes with the V-type H+-ATPase, much like ClC-5, and is therefore
thought to be involved in the eﬃcient acidiﬁcation of the vesicle and lacuna. Mutations in
ClC-7 underly several variants of osteopetrosis, a human disorder resulting from impaired
bone resorption, and are implied in lysosomal storage disease and neurodegeneration.48,49
Similar to the ClC-K channels it has been shown that ClC-7 directly interacts with a
β-subunit, however, the functional implications of this protein Ostm-1 are still unclear.30
It is obvious from the diﬀerent examples that ClCs play a diverse role in a variety of
physiological processes. Nevertheless, many of the detailed functions are to this date
only poorly understood and the key to comprehend their physiological function in the
organism lies in the behavior of these proteins on the molecular level.
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1.2.4 Molecular Architecture
Despite their functional diversity all ClCs share a common architecture resulting in a
conserved scaﬀold and a number of mutual features. On the level of quaternary struc-
ture ClCs have been shown to assemble into dimers.50 Moreover, they are thought to
only function as homodimers although, currents from functional concatemers of diﬀerent
ClCs have been described.51 Each of the two subunits harbors a single ion pathway
that is able to conduct ions independently, thereby giving the protein a double-barreled
architecture.21,52 The tertiary structure of the ClC family is complex and consists of a
catalytic domain that is comprised of 18 α-helices, 17 of which are embedded in the mem-
brane. Only some of these transmembrane α-helices span the membrane completely and
most are severely tilted with respect to the face of the bilayer. These features made the
topology assignment of the catalytic domain by biochemical methods extremely diﬃcult
and a conclusive picture only resulted from the determination of the high resolution struc-
tures of two bacterial homologs.21 The resulting topology of the membrane-embedded
pore domain of a single ClC subunit is shown in Figure 3. The catalytic pore domain
consists of two anti-parallel halves of 8 transmembrane helices. The structure revealed
that the residues, which coordinate the chloride ions during their passage through the
membrane are spread throughout the primary sequence of the protein.21 These sequence
motifs, which are highlighted red in Figure 3, are conserved among ClC channels and
transporters and they create speciﬁc binding sites for chloride in the translocation pore.
Both termini of the ClC subunit are located in the cytoplasm and in addition to the
catalytic domain all eukaryotic ClCs possess an intracellular domain that is located at
the C-terminus of the protein. A common feature of these cytoplasmic domains, which
will be discussed later in greater detail, is the presence of two CBS subdomains named
after their initial description in the enzyme cystathionine-β-synthase.53 The domains
are included in Figure 3 outlining the typical CBS fold and additional sequence features.
The location of these intracellular domains is interesting since they are attached to the
last transmembrane helix R that takes part in the ion coordination in the center of the
membrane, therefore implying a regulatory function. The conservation of the overall
topology among ClCs and the ion translocation pathway results in the presence of char-
acteristic signature motifs for the pore lining residues. The direct interaction of these
sequence stretches with the permeant ions are responsible for the observed ion conduction
properties of the protein.22
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Figure 3: Topology of Eukaryotic ClC Pro-
teins
A schematic view of the ClC subunit including
secondary structure elements. The membrane
embedded pore domain is shown in yellow with
the parts contributing to the ion selectivity ﬁlter
highlighted in red. The last transmembrane he-
lix (R) is labeled and the two cytoplasmic CBS
subdomains are shown in blue featuring their
characteristic topology. The variable sequence
stretches between the CBS subdomains and at
the C-terminus are labeled.
1.2.5 Principles of Ion Conduction
The general requirements to assure eﬃcient transport of ions across the membrane with
high speciﬁcity include the molecular recognition of the ion by interacting with the speciﬁc
parts of the protein. This will compensate for the loss of the hydration shell of the ion in
the pore and allows the protein to select the proper substrate among related ion species.
On the other hand it is crucial for this interaction not to be too tight to prevent the rapid
ﬂow of ions. Ensuring high selectivity while simultaneously allowing high conductance is
the major challenge in ion transport.54
Pore Properties In order to meet these demands ClCs have evolved three binding
sites for chloride in the middle of the membrane, by which they bridge two aqueous cav-
ities approaching from both sides towards the pore.21,22 These sites have been termed
Sext, Scen and Sin based on their location along the ion translocation pathway. The pore
is lined by four amino acid stretches that contribute to the ion coordination from distant
parts of the primary sequence. These motifs are conserved among the family: GSGIP in
the D helix, GKEGP in the F helix, GxFxP in the N helix and ﬁnally a Y in the last
transmembrane helix R. Interestingly all of these residues are located at the N-terminus
of their respective helices. The partial positive charge of the helix dipole might therefore
contribute to the favorable environment for anion binding.
The previously mentioned key properties of channels and transporters, namely selec-
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Figure 4: ClC Selectivity Filter
A side view of the ecClC dimer with the selectivity ﬁlter highlighted in red and two chloride ions
included in green. In bottom panels two close up representations of the ﬁlter with the chloride
coordinating residues depicted as sticks and the ions as red spheres. The closed conformation
shows the wildtype protein with the residue E148 blocking the pore by occupying the external
chloride binding site. The presumed open conformation is represented by the E148Q mutant
that allows an additional chloride ion to bind in the ﬁlter by an outward motion of the glutamine
side chain. In the close-up view of the selectivity ﬁlter the chloride binding sites, the glutamate
associated with the individual gating as well as the Tyrosine residue located on the R-helix are
labeled.
tivity, gating and conductance, can now be attributed to the molecular architecture of
the pore. The selectivity describes the ﬁdelity with which the protein can distinguish
between diﬀerent ionic species. Although this is less of an issue for chloride since it is by
far the most common anion under physiological conditions, it is nevertheless observed
that all ClC favor chloride over all other anions.
The mechanism of gating is usually a term to describe the controlled opening and clos-
ing of ion channels, either allowing passive diﬀusion through the pore or prohibiting it.
The equivalent mechanism in ion transporters, which can be performed by homologous
residues as will be described later, would correspond to activation or inactivation of the
transport cycle. The conductance is the quantitative measure of the rate of ion transloca-
tion through the protein. In the case of the ClC family this property is not very uniform
10
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and is ranging from 10 pS in ClC-055 and 1 pS in ClC-156,57 in the channels to only
about an approximate 2000 per second for the ecClC from E.coli .58 To illustrate this
enormous diﬀerence, one would have the chloride ﬂux of about 6 · 107 per second through
ClC-0 at a membrane voltage of -100 mV, as shown in Fiugre 1.2.5.
Assigning Structure to Function A joined discussion of the mechanistic features of
ClC channels and transporters appears diﬃcult when considering these vastly diﬀering
transport properties. Most of the functional work has been conducted on the muscle-type
channels, like ClC-0 and ClC-1, while the only structural information on the catalytic
domain originates from the crystal structures of two prokaryotic transporters, ecClC and
stClC. However, it has been shown that the conclusions drawn from the crystal structures
apply to a large extend also to ClC channels.59 Regardless of whether they allow passive
diﬀusion of chloride or coupled exchange for protons all ClCs share several common fea-
tures. They exhibit a strict selectivity for small monovalent anions, while cations, taken
aside protons in the transporters, do not permeate and iodide blocks the pore. In con-
trast to cation channels the ClCs do not possess a high interanionic selectivity, although
the preference was always found to be Cl− > Br− > NO3−.23
The plasma membrane channels ClC-1, -2 and -0 are the most thoroughly described
family members with respect to their electrophysiological behavior. Particularly ClC-0
has been extensively studied as it is expressed in high amounts in the electric organ of
Torpedo and has a high single channel conductance. This gave the possibility to record
currents from a single protein dimer in artiﬁcial lipid membranes.55 Next to the voltage
dependence of the currents through the channel some fundamental characteristics of the
protein structure became apparent. The equally spaced conductance states with their
binomial distribution argued for a protein with two identical and independent pores.52
Another feature is the existence of multiple gating mechanisms: 1. individual gating
acting on each pore separately 2. common gating aﬀecting both pores simultaneously.
Due to their kinetics in ClC-0 they have been also termed fast and slow gating, respec-
tively.60,61
Two Kinds of Gating The individual gating behavior is inﬂuenced by several factors
like changes in the external and internal chloride concentration, the external pH or the
membrane potential.62 The individual gating is strongly voltage dependent, the more
positive the membrane potential the higher is the open probability in ClC-0 and also
11
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Figure 5: Gating in ClC-0
The upper panel shows a single channel recording of ClC-0. Three conductance states can be
observed: closed (0), one pore open (1) and two pores open (2). Bursts of activity with rapid
ﬂuctuations controlled by the individual gates are observed. The appearance of these bursts is
interrupted by the temporary closing of both pores by the common gate, which is seen to have
slower kinetics. The panels A-D schematically depict some of the conformations in the protein
during these gating processes. The two subunits are colored in blue and red with each chain
forming an independent pore, each with an individual gate symbolized by lids. Chloride ions are
shown in green. A cylinder represents the last transmembrane helix R that coordinates a chloride
ion in the ﬁlter and has the C-terminal domains attached that assemble in the cytoplasm. The
panels (A) and (B) depict the two of the three possible states observed during the burst-like
activity, which is dominated by individual gate opening and closing. Panels (C) and (D) are two
possible mechanisms of common gate closing that acts on both pores in a concerted manner. In
(C) the cytoplasmic domains directly prohibit access to the pore while in (D) rearrangements in
the domains lead to a displacement of the R-helix, which in turn shuts down chloride ﬂux.
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ClC-1.62 This voltage dependence of channel opening involves an extracellular chloride
binding site outside of the selectivity ﬁlter and is thought to arise from the movement of
the permeant ion across the electric ﬁeld.63 This mechanism is profoundly diﬀerent from
voltage-gated potassium channels, where the gating charge is located on the protein in
form of several positively charged residues in the S4 voltage sensor segment.64,65 The
structural determinant of the indiviual gating process has been identiﬁed to be a single
glutamate residue (see Figure 4).22 This residue can either occupy the outer binding site
for chloride in the selectivity ﬁlter, thereby prohibiting ion ﬂow, or it may swing out from
this site allowing chloride to diﬀuse through the ﬁlter. This distinct gating mechanism
is located entirely within each subunit resulting in two pores that act independently of
each other.
The common gating mechanism on the other hand, acting in a concerted manner on the
two individual pores, is by far less well understood. Mutations in the dimer interface of
the catalytic domains57,66 as well as in the cytoplasmic domains have been described to
inﬂuence the common gate.67 The evidence towards an involvement of the intracellular
segments of the ClC in this regulatory process is discussed in more details in the following
section. The common gate is inﬂuenced by chloride concentration,68,69 temperature,70
pH and the membrane potential.71 In ClC-0 membrane depolarization favors common
gate closing.
Regulation in the ClC Transporters Since the plasma membrane channels have
been studied in more details than the transporters, it is unclear how the mechanisms
of individual and common gating translate into the functional mechanism of the latter.
Eukaryotic family members that have been conﬁrmed to function as secondary active
transporters are the two vesicular proteins ClC-4 and ClC-5.25,26 In addition to these
two human homologs, ecClC, of which the structure has been determined at high reso-
lution, was the ﬁrst ClC to have been recognized as a chloride proton antiporter.28 This
process is so far only poorly understood, although several residues have been identiﬁed
to be critical for the transport cycle. It has been shown that the glutamate residue in-
volved in the individual gating of the channels is essential for the coupling of chloride to
proton ﬂux in the transporters.28 When this residue is mutated the protein turns into a
constitutively open chloride conductor. Similar to this amino acid position at the outer
chloride binding site another glutamate residue towards the inside of the membrane has
been identiﬁed with comparable importance for the coupling.27 In contrast to the outer
glutamate, however, this inner glutamate residue is crucial only for proton transport,
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while not being part of the chloride pathway. Thus it has been speculated that the chlo-
ride and proton translocation pathways, although conjoint at the extracellular face of the
membrane, diverge towards the intracellular side.27
In addition, the coupling of the two substrates appears to be dependent on a tyro-
sine residue coordinating chloride in the central site of the selectivity ﬁlter.72 While
for the wildtype ecClC a transport stoichiometry of 1 proton per 2 chloride has been
determined,73 alterations in this conserved residue result in various degrees of slippage
making the protein more chloride selective.72 Until now no complete picture of the trans-
port cycle in ClC proteins has emerged, which is partly due to the fact that the proton
pathway in ecClC cannot be visualized crystallographically and the current resolution
of the structures is not high enough to identify all water molecules that are likely to be
involved in the coupling. It is intriguing, however, that it seems diﬃcult to strictly divide
ClC mechanistically into channels and transporters, since it becomes apparent that the
channels bear some transporter-related features and vice versa.
1.2.6 Cytoplasmic Domains
The modular domain architecture found in ClC proteins resembles the domain organi-
zation in a variety of other channel families that consist of a membrane bound catalytic
domain and a soluble regulatory module. All eukaryotic ClCs and a number of prokary-
otic homologs feature this characteristic composition and have at the C-terminus large
intracellular extensions. The only ClC of known atomic structure, however, the ClC
from E.coli does not have these cytoplasmic components. In the eukaryotic proteins
they have been shown to be critical for proper protein function.74,75 This is emphasized
by a number of mutations in the cytoplasmic domains of various family members that
lead to diseases like myotonia, Dent's disease or osteopetrosis.76 The intracellular exten-
sions vary among the diﬀerent homologs in length from about 155 to 398 amino acids.
As mentioned earlier a mutual feature is the presence of two CBS subdomains that are
conserved within the family. In contrast to the conserved subdomains, the interdispersed
linker and the so-called C-peptide following CBS2 are of variable length and sequence
composition.
CBS Subdomains CBS domains were initially described in the enzyme cystathionine-
β-synthase,53 but they are also found in a variety of functionally unrelated proteins like
metabolic enzymes, kinases, channels and transporters.77 The fold of these conserved
protein subdomains consists of three beta strands and two alpha helices in a β1− α1−
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β2− β3− α2 arrangement. CBS domains are usually found as pairs in tandem repeats
that are associating in an pseudo two-fold arrangement via the beta sheets 2 and 3 of the
two subdomains. While the beta strands are tightly interacting, the four alpha helices are
positioned on the periphery of the structure leaving a cleft in between the subdomains.77
In a number of cases two pairs of CBS domains have been seen to dimerize. In these
structures the CBS pairs from bacterial proteins are interacting via the alpha helices
in two possible arrangements either head-to-head (PDB accession 1VR9) or head-to-
tail78(Figure 6). The functional purpose of the CBS subdomains in the context of their
diﬀerent catalytic proteins is to this point not fully resolved, although a study has been
suggesting that they function as energy sensing modules.79 In this work it was shown
that isolated CBS domain tandems from various proteins are able to bind adenosine
nucleotides. This ﬁnding led to the hypothesis of CBS domains as sensors of the metabolic
energy state of the cell and regulators of the activity of their catalytic domains.
The Functional Importance of the Cytoplasmic Domains In the context of ClC
channels and transporters the function of CBS subdomains is still poorly understood, al-
though recent results give ﬁrst leads towards their purpose. The majority of studies have
employed mutational analysis in combination with biochemical and electrophysiological
methods to address the functional importance of the cytoplasmic domains in ClCs.67,74,80
While even minor changes in these domains can lead to drastic eﬀects in protein function,
the precise role in regulation is still uncertain. Initial approaches using large deletions in
the domains resulted in a failure of the proteins to reach the plasma membrane, whereas
in some cases it was possible to reconstitute functional protein upon co-expression of
the complementary protein fragments.74,75 These results suggested an involvement of
the intracellular domains in folding and traﬃcking of ClCs. Indeed, in the cases of the
human kidney transporter ClC-581 and the homolog from yeast scClC,80 studies correlate
traﬃcking eﬀects with alterations in the domains. In addition to these eﬀects, the cy-
toplasmic domains are also involved in modulation of the conductance properties, which
is impressively demonstrated by a single amino acid exchange in ClC-1 causing a shift
in the open probability of the channel that leads to myotonia.36 This and other natu-
rally occurring mutations result in an altered current phenotype of ClC-1 by changing
the voltage-dependence of the common gate. A number of additional residues have been
identiﬁed to be critical for the mechanism of the common gate.66,70,82 In this respect
the location of the intracellular domains is intriguing, since they are following the last
transmembrane helix R that is directly involved in coordinating a chloride ion in the cen-
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Figure 6: CBS Protein Dimerization
Examples of the diﬀerent modes of dimerization observed in CBS domain containing proteins.
The protein chains are shown as ribbons with the N-terminus colored in blue and the C-terminus
colored in red. The conventional head-to-head (A) and the head-to-tail (B) conﬁguration are
indicated by two structures of CBS proteins from Thermotoga maritima PDB accessions 1VR9
and 1O50 respectively. The novel mode of dimerization discovered in ClC proteins is exempliﬁed
by the cytoplasmic domain structure from the human ClC-5 (PDB accession 2J9L) and is shown
from the side (C) and the top (D) after a 90◦ rotation.
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tral site of the selectivity ﬁlter. The conserved tyrosine located on the R-helix has been
already discussed as being crucial for the coupling of proton to chloride ﬂux in the trans-
porters of the ClC family.72 It appears likely that the cytoplasmic domains may exert a
regulatory eﬀect on the protein by altering the position of the R-helix. There is indeed
evidence of large movements in the intracellular domains of ClC-0 that are associated
with the common gating of the channel from a study employing the "Förster resonance
energy transfer" combined with electrophysiological measurements.83 The mechanism of
how this rearrangement of the cytoplasmic domains alters the conductance properties will
require the structural analysis of these domains and their interaction with the catalytic
domain.
Structural Insights and Ligand Recognition Concerning the structural aspects of
the intracellular domains in ClC proteins, the ﬁrst insight came from the crystal structure
of the C-terminal domains of ClC-0 presented in section 2.1.2. The CBS tandem of CBS1
and CBS2 is forming a tightly interacting protein core similar to CBS motifs from other
proteins. Although not observed in the crystal, it was shown that two cytoplasmic do-
mains form a dimer in solution. Thus, the mode of this assembly of four CBS subdomains
remained uncertain. Interestingly a large part of the sequence of the linker connecting
the two CBS subdomains and the stretch after CBS2 was not resolved in the structure.
In a subsequent study described in section 2.1.3 these segments were found to be dis-
ordered in solution. The functional importance of these natively disordered sequence
segments that are present in ClC family members of the α-subfamily remains to be eluci-
dated. In a subsequent structural study on the cytoplasmic domains of ClC-5 presented
in section 2.2.2 several novel aspects of structure and function of these components were
revealed. The crystal structure showed the molecular interaction of speciﬁc residues with
the bound adenosine nucleotides and binding assays could conﬁrm the reports of ligand
binding.79,84 In addition, this interaction could be correlated with functional eﬀects on
the transport behavior of the protein when studied in electrophysiological experiments.
This regulatory eﬀect of nucleotide binding is an emerging facet of ClC function42 with
recent results in ClC-1 showing an alteration of the open probability of the channel upon
changed ATP concentration.8587 In addition, the crystal structure of the ClC-5 domains
contained a novel interaction of two CBS tandems profoundly diﬀerent from the previ-
ously observed head-to-head and head-to-tail conﬁgurations. This mode of cytoplasmic
domain dimerization in ClC proteins was later recognized to be conserved in ClC-Ka and
ClC-0 by cross-linking studies.88
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In summary these initial insights into the domain organization and the novel feature of
ligand regulation in ClC protein provide valuable leads for the future detailed study of
ClC function.
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Results
2.1 The Cytoplasmic Domain of ClC-0 from Torpedo mar-
morata
2.1.1 Introduction
The voltage-gated chloride channel from the electroplax organ of electric rays (ClC-0)
is a close homolog of ClC-1 from human skeletal muscle with 44 % sequence identity.
The electroplax organ consists of stacks of specialized muscle ﬁbers arranged in series
that can generate extremely high voltage. Acetylcholine receptors, sodium channels and
also ClC-0 are highly abundant in these noncontractile muscle cells. Since its discovery
in the 1980's ClC-0 has become the prototypical ClC channel, studied to establish im-
portant features like the homodimeric structure and the double-barreled architecture of
the family.52,55 Its function has been well characterized by reconstitution into planar
lipid bilayers and single channel recordings of a conductance of about 10 pS per pore
(see Introduction Figure 1.2.5).55 Initial work focused on the determination of the pore
properties of the channel, while soon the importance of the cytoplasmic domains for
its proper function was recognized. These domains have a length of about 285 amino
acids in ClC-0 following the last transmembrane helix. For these C-terminally located
segments the sequence identity with ClC-1 is only about 13 % arising from pronounced
diﬀerences in the interdispersed sequences between the CBS subdomains and after CBS2.
Comparison of the two CBS subdomains with their counterparts in ClC-1 yields about
50 % sequence identity suggesting a strong structural conservation. Limited insight into
the function of the cytoplasmic domains in ClC-0 was achieved by mutational analy-
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sis.76 It was shown that truncation of the domains resulted in non-functional protein.
On the other hand it was possible to reconstitute functional protein by splitting the
channel in the linker connecting CBS1 and CBS2 when both constructs were expressed
simultaneously,74 an observation that was also made in ClC-1.75 Biochemical attempts
to uncover the domain organization led to somewhat contradictory results leaving it un-
clear whether the CBS subdomains within one subunit are in contact. Furthermore it
needed to be resolved whether the cytoplasmic domains from two neighboring subunits
are interacting76 or not.89 Homology modeling of the ClC CBS subdomains onto known
CBS structures failed to conclusively rationalize the functional eﬀects of various point
mutations on the channel.76 The available biochemical and functional information on the
cytoplasmic domains in ClCs clearly marks their importance for the physiological func-
tion of the channels, however, the missing structural perspective complicates a correlation
of structure to function.
2.1.2 Crystal Structure of the Cytoplasmic Domain of the Chloride
Channel ClC-0
Aim of the Study At this point the main objective for this study was the determina-
tion of the ﬁrst high resolution structure of the isolated intracellular domains of a ClC
family member in order to establish a structural framework for these components. Inves-
tigation of the cytoplasmic domains of ClC-0 would reveal the structural organization of
the CBS tandem from one subunit potentially giving insight into the oligomeric state of
the cytoplasmic components.
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2.1.3 Supplementary Material
Supplementary Figures Figure S1 is an example of the 2Fo-Fc electron density map
giving an impression of the quality of model building at the resolution of 3.1 Å. Figure
S2 shows the asymmetric unit in the crystal including parts of the disordered linker
and C-peptide that could only be included as a poly-glycine chain in the model. These
elongated chains disobey the non-crystallographic symmetry in the asymmetric unit and
are most likely in a non-native conformation.
Figure S1: Electron Density Map of the ClC-0 Domain
Stereo view of a representative section of a 2Fo-Fc electron density map around the β-strands 1
to 3 of CBS1 is shown superimposed on the model. The density is contoured at 1.0 σ.
Figure S2: View of the Asymmetric Unit
Stereo view of a C-α trace of the asymmetric unit. The well deﬁned core structures of the two
copies of the ClC-0 domain in the asymmetric unit are colored in green and blue, respectively.
Residues modeled into residual weak electron density at the N-terminus and the linker are shown
in red.
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2.1.4 The Cytoplasmic Domain of the Chloride Channel ClC-0: Struc-
tural and Dynamic Characterization of Flexible Regions
Aim of the Study The structure of the cytoplasmic domains from ClC-0 laid the
foundation for the structural understanding of these components in ClCs, however the
lack of electron density for substantial parts of the protein was a suprising ﬁnding. Based
on the observations made in the crystal structure this following work characterizes the
ﬂexible regions of the C-terminus of the channel by nuclear magnetic resonance (NMR)
techniques. These regions had been recognized previously to contain regulatory motifs
that could lead to functional regulation of the protein upon phosphorylation90,91 or alter-
native splicing.82 The absence of electron density for large parts of the CBS subdomain
linker and the pronounced protease susceptibility of the C-peptide was a striking and
unexpected feature of this initial structural study. Although the primary sequence anal-
ysis of the cytoplasmic domains of members from the α-subfamily suggested that these
segments are natively disordered this hypothesis still required experimental proof. By the
use of nuclear magnetic resonance methods the linker region between CBS1 and CBS2
as well as the C-peptide following CBS2 could be analyzed in solution ideally answering
the question whether these regions are completely disordered or retain some secondary
structure but are ﬂexibly attached to the protein core.
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2.1.5 Supplementary Material
Materials and Methods
NMR Spectroscopy NMR spectra were including two dimensional (2D) [1H,15N]-
TROSY,92 and 3D [1H,15N] TROSY-HNCA93,94 and [1H,1H,15N]-NOESY95 (Figure S1)
were recorded at 7 ◦C on a Bruker Avance 600 MHz spectrometer equipped with a
cryogenic Z-gradient TXI probe and a Bruker Avance 900 MHz spectrometer. [1H,15N]-
TROSY were acquired with 1024 complex points in the direct dimension (1H) and 150
complex points in the indirect dimension (15N) using 32 scans with a 2H,15N labeled
protein sample. The TROSY-HNCA (Figure S1A) was recorded with 2048 points in the
direct dimension (1H), 128 points in the 15N dimension and 80 points in 13C dimension
using 8 scans with a 2H,15N,13C-labeled sample. The 15N-resolved [1H,1H] NOESY (Fig-
ure 1 B) was measured using the 2H,15N labeled sample with 1024 points in the direct
dimension (1H), 82 points in the 15N dimension and 256 points in 1H dimension and a
mixing time of 200 ms. Relaxation experiments were acquired using standard TROSY
based pulse sequences96 at 7 ◦C on 600 MHz spectrometer. The relaxation delays used
were 50, 125, 200, 275, 350, 425, 500, 575, 650, 725, 1000 and 1200 ms for longitudinal
relaxation rate constant measurements (R1) and 0.5, 3,10, 18, 30, 45, 60, 81, 99 and 120
ms for spin-spin relaxation rate constant measurements (R2). Estimates for R1 and R2
values (Figure 3) were obtained using a non-linear least squares ﬁtting of a two-parameter
monoexponential function to the measured peak intensities. Generalized order param-
eters were obtained from backbone 15N relaxation data using the program Modelfree
4.15.97,98 An isotropic model was used with the assumed correlation time of τc = 30 ns.
The correlation time was estimated from translational diﬀusion measurements, measured
with pulse ﬁeld gradient NMR methods, according to.99 The molecular weight was cal-
culated from the diﬀusion constant at 7 ◦C according to100,101 using the shape of the
dimeric structure modeled from the monomeric crystal structure of the ClC-O domain.
Relaxation data could be successfully modeled using two parameters, S2 and τe. RDC
data were obtained using 2H,15N labeled sample aligned with approximately 1 mM of
Pf1 phages (Asla Biotech).102,103 The couplings were measured using TROSY and 15N-
anti-TROSY spectra measured with and without Pf1 pages, recorded with 1024 points
in the direct 1H dimension and 300 points in the indirect 15N dimension with 64 scans at
600 MHz. All spectra were transformed with XWIN-NMR (Brucker), the analysis of the
spectral data was done with the software CARA.104 For the assignment the automated
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assignment program AutoLink105 was used. The 1H chemical shifts were referenced to
2,2 dimethyl-2-silapentane-5-sulfonate sodium salt (DSS).106 The 13C and 15N chemical
shifts were referenced indirectly using 13C/1H and 15N/1H gyro magnetic ratios.
Figure S1: NMR Spectra
(A) 3D [1H,15N] TROSY-HNCA recorded with 2048 points in the direct dimension (1H), 128
points in the 15N dimension and 80 points in 13C dimension using 8 scans with a 2H,15N,13C-
labeled sample. The sequential connectivity used for resonance assignment is indicated. (B)
15N-resolved [1H,1H] NOESY was measured using the 2H,15N labeled sample with 1024 points in
the direct dimension (1H), 82 points in the 15N dimension and 256 points in 1H dimension and a
mixing time of 200 ms. The intra-residue NOEs are indicated for this short sequence fragments.
Protein Expression and Puriﬁcation The construct of the ClC-0 cytoplasmic
domain contains the residues 525-805 of ClC-0 from Torpedo marmorata in the pET28-
b(+) expression vector (Novagen). Transformed E. coli BL21(DE3) cells were grown
at 37 ◦C in Silantes OD2 medium (2H, 15N labeled #105202 or 2H, 13C, 15N labeled
#107202) with 50 mg/l kanamycin to an OD600 of 1.0. Expression was induced by ad-
dition of 0.5 mM of isopropyl-D-thiogalactopyranoside (IPTG) and proceeded overnight
at 20 ◦C. Harvested cells were lysed by sonication in 50 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 5 mM MgCl2, 5 mM β-mercapto-ethanol, 200 mg/l lysozyme, 20 mg/l DNase,
leupeptin, pepstatin and 1 mM phenylmethyl sulphonyl ﬂuoride. The lysate was cleared
by centrifugation and loaded onto a Ni-aﬃnity column (Chelating Sepharose, Pharma-
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cia Biotech). The column was washed with buﬀer containing 15 mM imidazole and the
pure protein eluted with 300 mM imidazole. The protein was dialysed in buﬀer without
imidazole and concentrated to a concentration of 400 µM for subsequent measurements.
The measurements were performed in 10 mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl2
and 5 mM β-mercapto-ethanol. The protein was found to be stable in solution at 7 ◦C
during the course of the experiment.
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2.2 The Cytoplasmic Domain of Human ClC-5
2.2.1 Introduction
The structure of the cytoplasmic domains of ClC-0 showed the structural arrangement of
the CBS tandem in ClC proteins that is likely to be conserved in the family. The struc-
ture, however, does not account for a number of aspects associated with the intracellular
domains like the interaction with adenosine nucleotides or the dimeric assembly of the
C-termini from two subunits.
Compared to this, the cytoplasmic domains of chloride transporter ClC-5 vary in parts
considerably from the previously described regions in ClC-0. Although the conservation
of the CBS subdomains is substantial, the extended linker region and C-peptide are con-
siderably shorter in ClC-5. The importance of the intracellular domains is also in this
case illustrated by a number of mutations in this region that lead to Dent's disease.46
Unique in the ClC family, the linker between the two CBS subdomains in ClC-5 contains
a PY motif that has been shown to be important for regulating the surface expression of
the transporter via ubiquitination.81
ClC-5 is expressed mainly in the proximal tubule of the kidney.19 The malfunction of this
protein in humans is associated with Dent's disease, a recessive X-linked nephrolithiasis.44
On the subcellular level ClC-5 resides in endosomal membranes but has been described to
reach the plasma membrane upon heterologous expression.19 Whether ClC-5 also shut-
tles to the plasma membrane under physiological conditions is not clear. When studied
on the plasma membrane of heterologously expressing Xenopus oocytes the transporter
exhibits strong outward rectifying currents. Similar to the ClC homolog from E.coli,
ClC-5 was found to transport protons by exchanging them for chloride ions as a sec-
ondary active chloride proton antiporter.25,26 The contribution of chloride and protons
to the overall charge movement is estimated to be equal, suggesting a signiﬁcance of
this process in vivo.26 The recent advances in the elucidation of ClC-5 function on the
molecular level have rather obscured the picture of the physiological role of this protein
in the kidney. On one hand, the symptom of low molecular weight proteinuria in Dent's
disease patients suggests a role of ClC-5 in endocytosis.45 On the other hand, it has been
shown that the knock out of ClC-5 in mice leads to a reduced acidiﬁcation of vesicles
in the endosomal/lysosomal pathway.44 In this process ClC-5 had been thought to act
as a shunt for chloride ions preventing the building up of large electric potentials by the
V-type ATPase across the vesicular membrane. Thus, this function appears not to be
consistent with the recently discovered transporter function and the strong rectiﬁcation
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of the observed plasma membrane currents.
2.2.2 Nucleotide Recognition by the Cytoplasmic Domain of the Hu-
man Chloride Transporter ClC-5
Aim of the Study The structure of the cytoplasmic domain of ClC-0 left a number
of open questions that could potentially be addressed by the structural and biochemical
analysis of the cytoplasmic domains of ClC-5. The dimer assembly of the C-terminal
domains from the two subunits was to be conﬁrmed via analytical ultracentrifugation
and possibly resolved by native contacts in the crystal. The interaction of the domains
with adenosine ligands was to be assessed using binding assays, co-crystallization and
electrophysiolological experiments.
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2.2.3 Supplementary Material
Equilibrium dialysis
Methods The binding aﬃnity of radioactive adenosine nucleotides was measured by
equilibrium dialysis. Custom microdialysis chambers with 75 µl volume separated by a
dialysis membrane with a cutoﬀ of 8000∼Da were used. One chamber contained 300 µM
of puriﬁed protein in TBS* buﬀer (150 mM NaCl, 50 mM Tris pH 7.5, 5 mM MgCl2,
5 mM β-mercapto ethanol) and radiolabeled nucleotide, the other was ﬁlled with TBS*
and radiolabeled nucleotide. For each side of the chamber 55 µl of solution were applied.
Applied nucleotide concentration ranged from 10 to 600 µM ([2.8-3H] ATP, [2-3H] AMP
(Amersham) or [8-14C] ADP (Perkin Elmer)) to test binding of nucleotides over relevant
concentrations. Bound and free nucleotide concentrations were measured independently
after equilibration. As experimentally determined equilibrium was reached after 15 h
at 4 ◦C. The non-speciﬁc binding of protein to the chamber and the dialysis membrane
(about 20 %) was measured and taken into account. The non-speciﬁc interaction of
nucleotides with the protein can be assessed from experiments with the mutant D727A,
which shows negligible binding. For measurements two samples of 20 µl were drawn from
every chamber and mixed with 200 µl of scintillation liquid (Amersham). Samples were
measured in a 1450 Microbeta Plus liquid scintillation counter (Wallac) in opaque 96-well
plates with clear bottom (Wallac). The counts of the samples were in the range between
200 and 20000 cpm. The concentration of free and bound ATP was determined by
calibrating the cpm values with a standard curve of the radiolabeled ATP stock solution.
The same experimental setup was used for competition experiments. Experiments were
carried out with addition of 400 µM of radiolabeled ATP and equivalent amounts of
competing nucleotides. Bound ATP was compared to a reference where the competing
nucleotide was replaced by buﬀer.
Results The nucleotide recognition by the cytoplasmic domain of ClC-5 is mediated
by speciﬁc interactions of the protein with the adenosine base and the hydrogen bonding
to the sugar moiety (Article: Figure 2a). Using equilibrium dialysis techniques it could
be shown that the aﬃnity for adenosine nucleotides is in the range of 100 µM and that
the discrimination between the species AMP, ADP and ATP is poor (Article: Figure
3d). This ﬁnding is in line with the limited interaction of the β- and γ-phosphates of
the nucleotide with the protein. It remained to be shown that the protein is able to
discriminate adenosine nucleotides from related species like guanosine-5'-triphosphate,
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3'-5'-cyclic adenosine monophosphate or the metabolic precurser adenosine. To obtain
a qualitative answer of whether the ClC-5 domains are able to bind these molecules a
competition experiment was performed analogous to the results shown in the article in
Figure 3d. The results indicate that the binding of these compounds to the nucleotide
binding site in the cytoplasmic domains of ClC-5 is very low compared to the adenosine
nucleotides. Thus they suggest that all the observed protein ligand interactions are
contributing critically to the recognition of the molecule: 1. The interaction of T596 with
the 6'-amino group of the base. 2. Hydrogen bonding of D727 to the 2'- and 3'-hydroxyls
of the ribose moiety. 3. The backbone interaction of S618 with the α-phosphate.
Figure S1: Competition of Bound Radiolabeled ATP
Equilibrium dialysis experiments of ATP binding to the puriﬁed C-terminal domain of ClC-5 in
competition with unlabeled nucleotides. The reference shows the binding of 400 µM radiolabeled
ATP to the protein. In competition experiments 400 µM of unlabeled ATP, cAMP, GTP and
adenosine was added and the bound radiolabeled ligand was quantiﬁed and normalized to the
reference value. Averages from 3-4 independent experiments and their standard deviations are
shown.
Analytical Ultracentrifugation
Methods Sedimentation velocity experiments were performed with a Beckman XL-I
analytical ultracentrifuge with an An 50-Ti rotor at 4 circC. 12 mm epon double-sector
cells were ﬁlled with 400 µl 150 mM NaCl, 50 mM Tris (pH 7.5), 5 mM MgCl2, 5
mM β-mercapto-ethanol, and protein sample. Experiments were performed at protein
concentrations of 75 and 150 µM. Data were acquired using interference in continuous
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scan mode in 0.003 cm intervals at a rotor speed of 42,000 rpm. The data analysis was
performed with the c(S) module of Sedﬁt.107,108 The buﬀer parameters and partial-
speciﬁc volume of the protein were calculated by using Sednterp.109
Results The analytical ultracentrifugation experiments reveal that the protein exists
in an equilibrium of two species in solution, the monomer and the dimer. This situation is
similar but more pronounced than in the case of the ClC-0 cytoplasmic domains (Figure
3a1). The addition of ATP does not alter this equilibrium of the two species. At this
point it is unclear, if these observed oligomeric states are of functional importance in
the full-length transporter. However, it is likely that the high local concentration in
the dimeric assembly of two transporters will drive the cytoplasmic domains towards
dimerization.
Figure S2: Sedimentation Velocity Data of the ClC-5 Cytoplasmic Domain
Distribution of sedimentation coeﬃcients of the ClC-5 cytoplasmic domain without (a) and with
addition of 5 mM ATP (b) measured at 4 ◦C. The data shows a monomer/dimer equilibrium
of the protein with sedimentation values similar to those determined for the ClC-0 cytoplasmic
domain. No signiﬁcant change of the distribution is observed upon addition of ATP. The rms-
deviation of the ﬁts is 0.0063 and 0.0075 for a and b respectively.
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Two-electrode Voltage-Clamp In order to investigate the functional eﬀects of nu-
cleotide binding to the ClC-5 transporter the protein was heterologously expressed in
Xenopus l. oocytes. After an expression of 34 days the ClC transporter dominated
the current phenotype of the oocyte membrane and typical recordings of macroscopic
ClC-5 currents19 could be obtained by two-electrode voltage-clamp measurements (Fig-
ure S3). To assure that the observed currents were originating from the heterologously
expressed protein and not from endogenous proteins, measurements of water injected
oocytes were performed. These oocytes gave currents of 10- to 20-fold reduced ampli-
tude. Additionally, it was routinely conﬁrmed that the measured ClC-5 currents obeyed
the reported chloride over iodide selectivity19 causing a decrease in the current ampli-
tudes upon exchange of the oocyte buﬀer. To assess the inﬂuence of nucleotide binding
to the cytoplasmic domains the mutations that have been shown to abolish nucleotide
binding by equilibrium dialysis were tested functionally in Xenopus l. oocytes. Due to
the current-voltage characteristics of wt ClC-5 in heterologous expression, the protein
is only active over a rather limited voltage range above +30 mV. This observation is
seemingly contradictory to the function of the protein and will be discussed in more de-
tail in the following chapter. However, to circumvent this problem the mutations under
investigation were introduced in the background of the mutation E211A that has been
recognized to abolish H+ to Cl− coupling thereby converting the protein in a constitu-
tively open Cl− conductor.2426 This experimental setup made the voltage range below
+30 mV accessible to investigation and led to the discovery of the pronounced diﬀerences
at negative voltages of ClC-5 bearing domains with impaired nucleotide binding ability
(Figure S3 and S5).
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Figure S3: Two-electrode Voltage-clamp Recordings of Human ClC-5 in Xenopus l.
Oocytes
(a) ClC-5 wt. Representative current traces of an oocyte injected with ClC-5 mRNA (left).
Steady-state I-V curves were recorded at pH 7.4. Oocytes were clamped at -30 mV and a pulse
protocol was applied starting from 100 mV to -100 mV in 10 mV steps. The corresponding
current-voltage relationships in 96 mM Cl− (black) and in 80 mM I− (red) measured from the
same oocyte are shown (right). (b) Data as in panel a is shown for a representative oocyte
injected with ClC-5 E211A mRNA. (c) Data as in panel a is shown for a representative control
oocyte injected with water.
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Figure S4: Two-electrode Voltage-clamp Recordings of Human ClC-5 Mutants in
Xenopus l. Oocytes
(a) Representative current traces of an oocyte injected with ClC-5 D727A mRNA (left). The
current protocol is as in Supplementary Figure S4a. The corresponding current-voltage relation-
ships in 96 mM Cl− (black) and in 80 mM I− (red) measured from the same oocyte are shown
(right). (b) Data as in panel a is shown for a representative oocyte injected with ClC-5 Y617A
mRNA. (c) Data as in panel a is shown for a representative oocyte injected with ClC-5 S618A
mRNA.
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Figure S5: Two-electrode Voltage-clamp Recordings of Human ClC-5 Mutants in
Xenopus l. Oocytes
(a) Representative current traces of an oocyte injected with ClC-5 E211A / D727A mRNA
(left). The current protocol is as in Supplementary Figure S4a. The corresponding current-
voltage relationships in 96 mM Cl− (black) and in 80mM I− (red) measured from the same
oocyte are shown (right). (b) Data as in panel a is shown for a representative oocyte injected
with ClC-5 E211A / Y617A mRNA. (c) Data as in panel a is shown for a representative oocyte
injected with ClC-5 E211A / S618A mRNA.
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Structure Determination and Model Building The structure of the cytoplasmic
domains of ClC-5 in complex with ATP was solved by multiwavelength anomalous diﬀrac-
tion at three wavelengths using a selenomethionine substituted protein crystal. Analysis
of the solvent content of the crystals led to an assumption of 6 to 8 molecules in the
asymmetric unit, as these would result in Matthew's coeﬃcients of 2.8 to 2.1. The sub-
sequent search for selenium sites in the crystal resulted in the identiﬁcation of 29 sites,
in the following the calculation of an experimental electron density map that allowed
the tracing of 6 molecules in the asymmetric unit. An example of the electron density
around one of the ATP ligands is shown in Figure S6, which illustrates the high quality
of the experimental map in comparison to the ﬁnal model.
The placement of the 6 molecules in the asymmetric unit revealed that the chains are
Figure S6: Stereo View of Experimental Density of the Nucleotide Binding Region
in One Protein Chain in the Asymmetric Unit of the ClC-5 Domain-ATP Complex
The electron density at 2.5 Å is shown contoured at 1 σ. The map was calculated from amplitudes
and phases obtained from a three wavelength MAD experiment. The reﬁned structure of the
protein and the ATP molecule are shown as stick models, carbon atoms of the protein and the
nucleotide are colored yellow and orange respectively.
arranged as three pairs of dimers related by an imperfect non-crystallographic threefold
axis. The mode of interaction displayed by these dimers in the crystal is profoundly
diﬀerent from the dimerization interfaces observed in CBS proteins to this point.
Although ﬁve of the six diﬀerent chains in the crystal were well-deﬁned, the electron
density of the chain F was of considerably lower quality. This resulted in parts of the
molecule with missing or discontinous density for the amino acid side chains and peptide
chain. Analysis of the crystal packing partly reveals the reason for the apparent disorder
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Figure S7: View of the molecules in the asymmetric unit
The six molecules are shown individually colored in a ribbon representation tracing the Cα
positions. The proteins are depicted along the pseudo threefold axis (left) and rotated by 90 ◦
from the side.
of the chain F. While the proteins pack rather tightly in two dimensions of the crystal,
namely along the axes y and z, only limited protein contacts are seen along the x-axis.
This results in a layered appearance of the crystal lattice with large solvent cavities along
the yz-plane. One of the CBS subdomains of chain F is exposed in this solvent channel
resulting in the insuﬃcient stabilization by crystal contacts. Due to the higher ﬂexibility,
this part of the chain could only be modeled with elevated B-factors compared to the
other chains (Figure S8). In turn, the observed ﬂexibility of parts of the asymmetric
unit contributes to the relatively high R-factor of the structure, when compared to the
average of structures at this resolution. Nevertheless, a model with good geometry could
be build and reﬁned using non-crystallographic symmetry restraints to the other chains.
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Figure S8: View of the Crystal Packing
The packing of the crystal lattice is shown by symmetry related molecules in ribbon representa-
tion. The molecules are colored according to the main chain B-factors with blue for the lowest
and red for the highest values. The dimensions of one unit cell are depicted as red lines. The
packing is displayed as a view along the cell axis, with (A) along x, (B) along y and (C) along z.
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Chapter 3
General Discussion and Outlook
The family of ClC channels and transporters is ubiquitously expressed and involved
in a variety of important physiological processes.32 The high resolution structures of
the membrane-embedded catalytic domain has led the ﬁeld to begin to understand the
molecular determinants of ion conduction in these complexly regulated proteins.21,22
Nevertheless, structural and functional investigations have to go hand in hand in order
to unravel the detailed mechanisms of ClC function. A striking example is the recent
discovery of the transporter function of ecClC, the ClC homolog from E.coli, by elec-
trophysiological28 means and, on the other hand, the structure-guided identiﬁcation of a
glutamate residue that forms part of the proton pathway over the membrane.27 These
astonishing revelations have caused a change of paradigms concerning the mechanisms
of channels and transporters, since these hitherto strictly separated functions can be at-
tained by the same structural scaﬀold. This dualism of ClC function as voltage-gated
chloride channels versus secondary active chloride proton transporters also extends to
the human isoforms.25,26 Another striking aspect of ClC function is the intricate regu-
lation of the gating behavior that governs the ion conduction. Recently the cytoplasmic
domains present in all eukaryotic ClCs have been recognized to be intimately involved in
several regulatory processes. One of these is the association of the common gate with the
domains and the coincidence of large movements in the cytoplasmic components upon
gating.83 This is in line with an observed large temperature dependence of the common
gating process70 and the identiﬁcation of several point mutations in the intracellular do-
mains that disrupt this gating mechanism.76 A second emerging aspect is the regulation
of ClC proteins in response to nucleotide binding to the cytoplasmic domains.8587 These
studies have described this novel feature of the ClC family by electrophysiological meth-
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ods in the muscle type channel ClC-1. In the case of ClC-1, intracellular ATP seems to
inhibit the activity of the channel by decreasing the open probability. This eﬀect is po-
tentiated by low intracellular pH85,87 and is therefore believed to underlie the increased
excitability of skeletal muscle during acidosis caused by intense activity.110 Yet, to un-
derstand the underlying mechanistic principles there is an increasing need for structural
information.
In this work the cytoplasmic components of two ClC proteins have been studied, one
from the voltage-gated chloride channel ClC-0 and the other from the secondary active
transporter ClC-5. The structure of the cytoplasmic domains from ClC-0, as described
in section 2.1.2, is the ﬁrst high resolution model for the intracellular components in ClC
proteins, setting the structural framework for the cytoplasmic domains in the ClC family.
It was found that the two CBS subdomains are tightly interacting and that the N- and
C-terminus are positioned on the same face of this well packed CBS tandem. Analytical
ultracentrifugation experiments revealed the quaternary structure of the protein to be
a dimer in solution alike to the assembly of the membrane domain. In contrast to the
well-folded protein core, large parts of the linker connecting the CBS subdomains and
the C-peptide were not resolved in the structure, possibly due to inherent ﬂexibility. In a
subsequent study (section 2.1.3) these stretches were characterized with NMR methods
conﬁrming the intrinsic disorder in solution. This novel feature in certain homologs of
the α-subfamily, namely ClC-1, ClC-2 and ClC-0, had so far not been recognized. The
functional importance is highlighted by altered functional behavior of some ClCs as a re-
sult of phosphorylation,90,91 alternative splicing82 or point mutations in these regions.36
The underlying purpose of the disordered and highly mobile sequence segments is still
poorly understood and requires further investigation.
The cytoplasmic domains of the secondary active transporter ClC-5 on the other hand
lack these extended disordered segments. Although the fold of the CBS tandem appears
very similar in ClC-5, the structure of the intracellular domains reveals two novel fea-
tures: 1. The binding of ATP and ADP to the protein; 2. The dimeric assembly of two
cytoplasmic domains later conﬁrmed by a study on the domains of ClC-Ka.88
Several studies have previously suggested the direct interaction of adenosine nucleotides
with the intracellular domains of diﬀerent ClCs.79,84,86 In an attempt to rationalize the
molecular interaction with the ligands, homology modeling was used to map the binding
site based on the CBS domains of IMPDH.86 This binding site however does not match
the interaction now observed in the complex structure, thus emphasizing the need for
detailed structural information. Analysis of the binding pocket shows the nucleotide
64
bound in a novel conformation in comparison to known ATP binding sites. The base
and the sugar moiety are inserted into a groove of the protein making several speciﬁc
interactions, while the phosphate groups are pointing towards the solvent. This mode
of nucleotide binding has thereafter been also observed in the CBS domains of the pro-
tein AMPK.111,112 The binding aﬃnities for the diﬀerent nucleotides AMP, ADP and
ATP of the cytoplasmic domains of ClC-5 have been determined and appear to be very
similar in the range of 100 µM. Mutating residues involved in speciﬁc contacts with the
nucleotide caused a drastic reduction of the binding aﬃnities. Interestingly, the loss of
nucleotide binding caused by these mutations did not alter the current phenotype of
the transporter when studied in heterologous expression. Nonetheless, an altered current
voltage relationship was observed when the mutations were introduced in the background
of a mutation of the glutamate corresponding to the individual gate in the channels.22
This well characterized mutant causes ClC-5 to uncouple chloride and proton transport
resulting in selective chloride conduction over a broad voltage range. This includes the
region of negative potentials where the wildtype protein is usually inactive.24 At those
voltages the transporter would be extruding chloride from the cytoplasm, while taking up
protons from the extracellular space or the internalized vesicle. The results suggest that
binding of nucleotides to the intracellular domains seems to aﬀect the outward ﬂux of
chloride. In the case of ClC-5 the mutations that abolish the binding of nucleotides cause
a pronounced reduction of the ion ﬂow in the negative voltage range. Interestingly, in
contrast to these ﬁndings the addition of ATP,8587 as well as AMP,86 to the intracellular
side of ClC-1 appears to inactivate the channel by decreasing the open probabilty. While
results in ClC-1 can be conclusively integrated into its physiological role the situation in
the case of ClC-5 is rather convoluted.
The physiological function of ClC-5 is proposed to be the shunt of chloride ions into
endosomal vesicles that are getting acidiﬁed by V-type ATPases.45 In this role the pro-
tein counteracts the building up of a large electric potential across the membrane, which
would prevent further proton transport into the vesicle. The details of this function are
still poorly understood and several observations seem paradox with regard to this task,
especially the action as secondary active transporter.25,26 For one, to serve the role as a
chloride shunt the protein would need to allow chloride to ﬂow in the outward direction
with respect to the cytoplasm moving chloride to the extracellular space or inside the
vesicles. However, this direction of chloride transport is not observed when the trans-
porter is studied on the plasma membrane. Secondly, the exchange of chloride against
protons of ClC-5 would counteract the eﬀorts of the V-type ATPase to acidify the vesicle
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by moving protons out of the lumen. In order to explain the obscure involvement of
ClC-5 in the acidiﬁcation of endosomal and lysosomal compartments one could imagine
auxiliary factors that activate the transporter under physiological conditions. Another
speculative idea would be to switch ClC-5 from a transporter to a channel during the
maturation of an endocytotic to a lysosomal vesicle. In this scenario the transporter
ClC-5 could use the initial high chloride concentration present in the early endosome,
stemming from the extracellular milieu, to acidify the vesicle. Once the V-type ATPases
are active on the maturing vesicle, a putative channel ClC-5 could then allow chloride
ions to enter the vesicle dissipating the electric potential. Under both circumstances
the required outward chloride ﬂux might be activated and the regulation via nucleotide
binding could become relevant. Still, the interesting observation that nucleotide binding
has a functional eﬀect does not directly explain the physiological rationale behind this
regulatory mode. It has been hypothesized that CBS domains serve as energy-sensing
modules for the metabolic state of the cell.79 In order to fulﬁll this task by nucleotide
binding the protein could either sense the concentration change of one of the adenosine
nucleotide species or changes in the ratio of ATP:ADP:AMP by competitive interac-
tion.111,113 In light of this mechanism the experimentally determined binding aﬃnities
of the nucleotides to the isolated ClC-5 domains are puzzling, since ATP, with a cellu-
lar concentration of 2-5 mM, would be bound virtually all the time. Also a diﬀerential
binding of ATP and AMP seems unlikely since this competition would require a much
higher aﬃnity for AMP due to its low cellular concentration.114
Although a number of valuable advances towards understanding of the regulatory role of
the cytoplasmic domains in ClC channels and transporters have been made, a number
of questions remain:
1. How are the domains positioned with respect to the catalytic domains and the
pore?
2. How do the domains inﬂuence the conduction behavior of the channel or transporter
and which conformational changes accompany the common gating?
3. What is the physiological relevance for the regulatory mode of nucleotide binding
and how is it transduced?
To address these issues structural and functional methods have to be combined. Some
aspects will have to be worked out by detailed electrophysiological analysis like the phys-
iological importance of the ligand recognition by the cytoplasmic domains. To resolve
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the organization and arrangement of the catalytic and intracellular domains it is crucial
to determine a structure of a ClC protein that, in contrast to ecClC, contains both com-
ponents, membrane embedded and cytosolic domains. The determination of membrane
protein structures is still a challenging task, because of the various problems arising at
all stages of a crystallization project starting from expression levels, acquisition of ma-
terial at high purity and proper crystal packing to obtain well diﬀracting crystals. In
a number of cases it has proven useful to turn to prokaryotic homologs for structural
studies, since they are generally more readily expressed, biochemically more stable and
more amenable to crystallization.115118 The structures of these prokaryotic homologs
could serve as structural models for the physiological relevant eukaryotic relatives, like in
the potassium channel ﬁeld, where a number of crystal structures of the channel and its
auxiliary modules (e.g. the voltage sensor or the ligand binding domains) led the ﬁeld to
the fundamental principles of ion selectivity and conduction.119 In the case of the ClC
family a number of prokaryotic homologs exist that share the domain architecture of the
eukaryotic proteins, containing both the catalytic domain with all the conserved features
of the selectivity ﬁlter and the cytoplasmic domains with both CBS subdomains. These
proteins are promising candidates for structural and electrophysiological studies that ad-
dress the questions raised above. In the appendix .1 preliminary experimental data of
the characterization of the homologous ClC protein from the archaebacterial organism
Haloferax volcanii is included.
Despite initial steps towards the understanding of the molecular function of ClCs, the
challenges remaining in the ﬁeld are numerous and much work still lies ahead to unravel
the detailed mechanisms in this remarkable ambivalent family of proteins.
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.1 Cloning, Expression and Biochemical Characterization of
Prokaryotic ClC Homologs
.1.1 Introduction
In order to address the pending questions of ClC mechanism and regulation, as they were
outlined in Chapter 3, the combined structural and functional analysis of these proteins
is required. In an eﬀort towards this goal I have identiﬁed a number of prokaryotic
ClC homologs that share the modular domain organization of the eukaryotic proteins.
These proteins show the conserved hallmarks of the ClC selectivity ﬁlter and include the
extended intracellular segments with a pair of CBS domains. Due to these attributes
the prokaryotic homologs are excellent candidates to serve as model systems to resolve
the molecular architecture and the mechanism of ligand regulation in the ClC family.
In several similar cases it has been a successful approach to use prokaryotic proteins to
develop structural models for their physiologically relevant eukaryotic homologs.
In the following I will give a summary of the employed strategy to obtain suﬃcient
amounts of puriﬁed protein for structural studies or the reconstitution into lipid bilayers
to carry out functional experiments. The description of the methodology applied for
exploring detergent stability and puriﬁcation conditions will be discussed mainly on the
example of the ClC homolog from Haloferax volcanii summarizing the preliminary data
towards the structural characterization.
.1.2 Results and Discussion
ClC homologs Prokaryotic ClC homologs were identiﬁed by sequence homology to
diﬀerent human ClC proteins, like ClC-1 or ClC-5, using tblastn.120 In Table 1 the
organisms are listed, from which homologs have been chosen for cloning into E.coli ex-
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Figure A1: Prokaryotic ClC Homologs
Table of the diﬀerent ClC homologs that were cloned into E.coli expression vectors. The organ-
isms are grouped into bacterial and archaebacterial origin and the sequence homology/identity
to the human ClC-5 is stated according to a sequence alignment using the Blosum62 matrix of
AlignX (Informax). For comparison the homology values for ClC-0 and the ecClC, in the latter
case only with the transmembrane part of ClC-5, are given. The two cyanobacterial homologs
G.violaceus and N.punctiforme include an additional protein domain at the C-terminus, the USP
(universal stress protein) domain, which was excluded from the alignment.
pression vectors. Subsequently the strains were obtained from either DSMZ, ATCC or
the Pasteur Institute.
Cloning, Expression and Membrane Preparation The genomic DNA from the
diﬀerent strains was prepared as described previously,121 in short: DNA was prepared by
resuspending pelleted cells in 500 µl lysis buﬀer (0.25 M Tris-HCl [pH 8.0], 25 % [wt/vol]
sucrose, 10 µg/ml lysozyme) and incubated at 37 ◦C for 1 h. Sarkosyl (1 % [vol/vol])
and proteinase K (200 µg/ml) were then added, and the cell lysate was incubated at
65 ◦C for 1 h. Proteins were extracted once with phenol-chloroform (25:24) and once
with chloroform-isoamyl alcohol (24:1) before precipitating nucleic acids with one vol-
ume of isopropanol and 0.4 volumes of 7.5 M ammonium acetate at room temperature.
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Figure A2: Schematic Vector Map
A schematic map of the hvClC expression construct in the pET28b vector. The sequence features
are indicated as grey boxes from the 5' to the 3' direction on the vector. The open reading frame
(ORF) followed by the 3C protease cleavage site and ﬁnally the histidine tag. On the top of the
vector the diﬀerent restriction sites used to assemble the construct are indicated by arrows. This
cartoon is exemplary also for the diﬀerent homologs mentioned in Appendix Figure A1.
Nucleic acids were recovered by centrifugation, washed once with 70 % (vol/vol) ethanol
and resuspended in TE (10 mM Tris-HCl [pH 8.0], 0.1 mM EDTA) prior to storage at
-20 ◦C. The cloning of the desired DNA sequences was performed by PCR with primers
containing compatible restriction sites for diﬀerent E.coli expression vectors, like pET28b
or pQE60, containing poly-histidine aﬃnity tags either at the N- or C-terminus of the
protein.
Of the number of diﬀerent homologs that were tested for expression in E.coli only about
25 % showed detectable signals in western blot analysis. This reduced the number of
investigated candidates drastically and in the remainder I will limit the description of
the protein analysis on one candidate protein. The homolog from the archaebacterium
Haloferax volcanii (hvClC) that will be discussed in the following was cloned into a mod-
iﬁed pET28b with a C-terminal His10 fusion tag.
For protein expression the construct was transformed into chemically competent BL21-
(DE3) cells and the culture was grown in LB to an OD600 of 1 and induced for overnight
expression at 20 ◦C with 0.5 mM IPTG. The cells were harvested by centrifugation and
resuspended in lysis buﬀer: 50 mM sodium phosphate (pH 8), 300 mM NaCl, 200 mg/l
lysozyme, 20 mg/l DNase, leupeptin, pepstatin and 1 mM phenylmethyl sulphonyl ﬂuo-
ride, all the following steps were carried out at 4 ◦C. The cells were disrupted using an
EmulsiFlex (Avestin) and the lysate was cleared by centrifugation for 35 min at 12000 g.
Subsequently, the membrane fraction was pelleted by centrifugation at 100000 g for 1 h.
The isolated membranes were washed once in 50 mM sodium phosphate (pH 8), 300 mM
NaCl (Buﬀer A) by resuspending followed by a second centrifugation step. Buﬀer A was
used throughout the following steps. Membranes were ﬂash-frozen in liquid nitrogen and
stored at -80 ◦C.
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Figure A3: Detergent-Extraction of hv-
ClC
Western blot analysis of a detergent extraction
of the hvClC. The extraction performance of
four diﬀerent detergents was tested by analy-
sis of the solubilized fraction (S) and the mem-
brane pellet (P) after extraction and centrifu-
gation. The signal for the hvClC is observed
in the center of the lane and is in all cases the
predominant band. The eﬃciency of the de-
tergents n-Decyl-β-D-maltopyranoside (DM),
Polyoxyethylene(9)dodecyl ether (C12E9), n-
Dodecyl-N,N-dimethylamine-N-oxide (LDAO)
and Fos-choline-12 (Fos12) is judged by com-
parison of the ratio of signal in the S to the P
fraction.
Detergent Extraction The isolated membrane fraction was resuspended in Buﬀer
A at a ratio of 10 ml per g of membrane and solubilized in 2 % of detergent for 2 h.
Initial trials were carried out in 1 ml fractions using diﬀerent detergents to analyze the
eﬃciency of the solubilization. The unsolubilized lipid fraction was pelleted by centrifu-
gation (100000 g for 1 h) and the two fractions were analyzed by western blot detecting
the expressed protein via an α-his antibody (Roche). The analysis (Figure A3) re-
vealed that all of the tested detergents were suitable to extract a large portion of the
protein from the membrane, although the eﬃciency diﬀered from almost complete ex-
traction in Fos-choline-12 (Fos12) to partial extraction in n-Decyl-β-D-maltopyranoside
(DM), n-Dodecyl-N,N-dimethylamine-N-oxide (LDAO) and Polyoxyethylene(9)dodecyl
ether (C12E9).
Detergent Stability Analysis In order to assess the protein stability in diﬀerent
detergents the migration behavior on a gelﬁltration column was exploited to diﬀerenti-
ate mono-disperse from aggregated sample. In a simple assay, similar to a previously
described approach,122 the crude membrane extract from the small scale detergent solu-
bilization is ﬁltered with a 0.45 µm spin-ﬁlter and applied on a Superdex200 column (GE
Healthcare). The retention volume of the protein of interest was determined by western
blot analysis of the elution fractions starting from the void volume of 7 ml up to 13 ml.
To conﬁrm that the technique faithfully reﬂects the elution proﬁle of the puriﬁed pro-
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Figure A4: Gelﬁltration Analysis of ec-
ClC
Comparison of the elution proﬁle of crude
membrane extract versus puriﬁed ecClC
from a Superdex200 size exclusion column
in DM. The upper panel shows the plot
of the western blot quantiﬁcation of the
crude membrane fraction gelﬁltration (mid-
dle panel). The lower panel shows a
coomassie stained SDS-PAGE of a gelﬁltra-
tion run of puriﬁed ecClC. The slight shift
towards higher elution volume is due to the
increased volume of the tubing of the sys-
tem with connected UV detector.
tein gelﬁltration was initially performed on samples of ecClC, both puriﬁed and as crude
extract in DM. The protein was expressed and puriﬁed as described previously21 and
the elution proﬁles were analyzed by UV280 absorbance and coomassie staining for the
puriﬁed protein and by western blot for the unpuriﬁed sample. The western blot analysis
was carried out with the chemiluminescent western blot detection kit (Millipore) and the
signals were evaluated as integrated peak intensities using the software AIDA (Raytest).
The comparison, as shown in Figure A4, showed a good agreement of the retention vol-
umes.
In order to determine the detergent stability of hvClC in crude membrane extracts, the
samples were loaded on the gelﬁltration column and 500 µl fractions were collected start-
ing at the void volume of the column (Figure A5). The protein amount in the fractions
was quantiﬁed and plotted in comparison to the values for the ecClC as reference. The
results indicate that the protein shows heavy aggregation in DM with the majority of
the protein eluting in the void volume. In the case of C12E9 an intermediate behavior
could be observed with part of the protein eluting at about 10.5 ml corresponding to
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Figure A5: Gelﬁltration Analysis of hvClC
Western blot analysis of the Superdex200 size exclusion elution proﬁles of crude membrane
extracts of hvClC. Membrane extracts of hvClC in four diﬀerent detergents were separated by
gelﬁltration and analysed by western blot quantiﬁcation. The western blots and the resulting
plots are depicted.
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an appropriate molecular weight of the dimeric hvClC, which is shifted towards a lower
elution volume with respect to the ∼30 kDa smaller ecClC. Nevertheless, a large amount
of the protein showed aggregation suggesting limited stability in C12E9. For the deter-
gents Fos12 and LDAO on the other hand the analysis revealed a preferential elution at
10.5 ml suggesting these detergents extract the hvClC natively from the membrane and
the protein remains stable in solution during the course of the experiment. The asym-
metry in the peakshape of Fos12 sample is most likely due to the strong signals on the
western blot caused by the comparatively higher amounts of extracted protein. Hence,
these results led to the choice of the LDAO and Fos12 for extraction and puriﬁcation in
the subsequent experiments.
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Figure A6: Coomassie
Stained Gel of Puriﬁed
hvClC
SDS PAGE of the hvClC
(∼70 kDa) elution fractions
after IMAC.
Protein Puriﬁcation For the puriﬁcation of the hvClC membrane extracts were pre-
pared using either LDAO or Fos12 and the protein was bound in batch for 2 h to Protino
Ni-IDA resin (Macherey-Nagel) in a ratio of about 1 ml bed volume per 10 ml of extract.
The loaded resin was applied to a Econo-chromatography column (Bio-Rad) and washed
with 12 column volumes of buﬀer containing 15 mM of imidazole. The protein was eluted
with buﬀer containing 300 mM imidazole and the purity was assessed by SDS-PAGE and
coomassie staining (Figure A6).
As an additional puriﬁcation step and to further evaluate the oligomeric state of the
protein and potential aggregation behavior the puriﬁed protein was subjected to size
exclusion chromatography on a Superdex200 column. The elution pool from the immo-
bilized metal aﬃnity chromatography was concentrated and separated by size exclusion
chromatography. The analysis of the elution proﬁle revealed that during the puriﬁcation
higher molecular aggregates of the protein are being formed causing the hvClC to elute
in the void volume of about 8 ml (Figure A7). Only a minor fraction of the protein
was found to migrate as the dimer, when a not concentrated sample was analyzed. This
dramatic aggregation behavior was observed regardless whether the protein was digested
with 3C protease to remove the aﬃnity-tag or prepared in LDAO or Fos12.
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Figure A7: Gelﬁltration of Puriﬁed hvClC
Gelﬁltration elution proﬁle of the puriﬁed hv-
ClC, plot of the absorbance at 280 nm. The
concentrated sample of the hvClC was loaded
on a Superdex200 size exclusion column and
the protein elution was monitored by plotting
the Abs280. An example of the puriﬁcation in
LDAO is shown, however, comporable results
were also obtained in Fos-12.
In summary, the screening of several prokaryotic ClC homologs led to the identiﬁ-
cation of a potential candidate for structural analysis. During the further biochemical
characterization of the ClC protein from Haloferax volcanii an extraction and puriﬁcation
protocol could be established for two detergents. However, the assessment of the protein
quality revealed that during the puriﬁcation process the hvClC formed higher molecular
aggregates making it unsuitable for crystallographic studies.
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